Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C693
http://purl.obolibrary.org/obo/NCIT_C693
|
|---|---|
| Preferred Name | Nimustine |
| Definitions |
A nitrosourea with antineoplastic activity. Nimustine alkylates and crosslinks DNA, thereby causing DNA fragmentation, inhibition of protein synthesis, and cell death. (NCI05)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A nitrosourea with antineoplastic activity. Nimustine alkylates and crosslinks DNA, thereby causing DNA fragmentation, inhibition of protein synthesis, and cell death. (NCI05) |
|---|---|
| label | Nimustine
|
| prefLabel | Nimustine
|
| Legacy Concept Name | Nimustine
|
| in_subset | |
| Preferred_Name | Nimustine
|
| Is_Value_For_GDC_Property | |
| Chemical_Formula | C9H13ClN6O2
|
| Maps_To | Nimustine
|
| PDQ_Open_Trial_Search_ID | 38853
|
| UMLS_CUI | C0028096
|
| FDA_UNII_Code | 0S726V972K
|
| prefixIRI | NCIT:C693
|
| NCI_Drug_Dictionary_ID | 38853
|
| Contributing_Source | FDA
|
| subClassOf | |
| Has_Salt_Form | |
| code | C693
|
| type | |
| ALT_DEFINITION | A substance that is being studied in the treatment of brain cancer. It belongs to the family of drugs called nitrosoureas.
|
| NSC Number | 245382
|
| PDQ_Closed_Trial_Search_ID | 38853
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| CAS_Registry | 42471-28-3
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |